Navigation Links
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Date:3/17/2008

CANTON, Mass., March 17 /PRNewswire/ - Organogenesis, Inc., announced today that Damien Bates, MD, PhD, FRACS (Plast.), has joined the company as vice president of medical affairs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM095)

Dr. Bates combines more than twelve years of surgical practice with solid regenerative medicine industry experience. He has practiced in orthopedic, dermatologic, vascular, oncologic and general surgery, infectious diseases and intensive care, both in the U.S. and Australia. An accomplished board-certified plastic and reconstructive surgeon, Dr. Bates will serve an important and multi-faceted role within Organogenesis. In addition to leading the company's clinical study department, Dr. Bates will strengthen Organogenesis' links to the surgical community. He will also impact patient lives by collaborating with Organogenesis research and development teams to guide new product development from lab science through to approved products.

"This is an exciting time for Organogenesis, and Damien's appointment serves to solidify our executive team," said Geoff MacKay, chief executive officer of Organogenesis. "Damien's wealth of experience in tissue engineering, stem cell biology and surgical wound healing is a great fit for Organogenesis as we grow our company, as well as our product pipeline."

Organogenesis is in the midst of a large expansion, both in employees as well as facilities, and also recently acquired the electro-spinning platform technology company NanoMatrix. The company is currently developing a number of new products, and recently launched the first-ever direct-to-consumer (DTC) educational campaign for a living cell therapy (its flagship product Apligraf(R)).

Prior to joining Organogenesis, Dr. Bates served as attending plastic and reconstructive surgeon for the University of Colorado, The Children's and Denver Health hospitals. Most recently, Dr. Bates was with Baxter BioSurgery as a global associate medical director in regenerative surgery. Dr. Bates is licensed to, and has practiced medicine in, both the U.S. and Australia, with more than 12 years of clinical experience in surgery, infectious diseases and intensive care.

Dr. Bates' expertise includes a focus in tissue engineering, stem cell biology and wound healing. He has presented at numerous annual scientific meetings and medical conferences, including the U.S. Society of Developmental Biology, the Surgical Research Society of Australasia, the Society of University Surgeons and the 7th International Conference on Limb Development & Regeneration. His research has been published in a variety of journals, including Developmental Biology, the Annals of Plastic Surgery and Plastic & Reconstructive Surgery.

About Regenerative Medicine

A new frontier in healthcare, regenerative medicine is an evolving therapeutic approach that utilizes living cells to repair or replace body tissue damaged by injury, disease or the aging process. It is a multidisciplinary field involving biology, medicine and engineering.

Regenerative therapies rely on the body's own natural ability to repair and regenerate, and enable the body to heal itself Regenerative medicine also empowers scientists to grow living cells, tissues and organs in the laboratory, and to safely implant them into the human body for the purposes of healing.

The related terms "Tissue Regeneration," "Tissue Engineering" and "Stem Cell Therapies" are often used to refer to some of the activities under the umbrella of regenerative medicine.

About Organogenesis, Inc.

Massachusetts based Organogenesis, Inc. is the world's most successful regenerative medicine company and is focused in areas of bio-active wound healing, bio-surgery and bio-aesthetics. Organogenesis delivers living tissue "on demand," and its mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. For more information, visit http://www.organogenesis.com.


'/>"/>
SOURCE Organogenesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
2. Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record
3. Study names 5 factors of social ills in energy, mining and logging communities
4. Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
5. Nellson Nutraceutical Names New Directors and Interim Chief Executive Officer
6. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
7. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Numira Biosciences Names New Board Member
10. Senior Lifestyle Corporation Names John Cobb as President and CEO
11. Women Health Care Executives Names Genomic Health President Kimberly Popovits as Woman of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... provides business development, education, networking and recognition opportunities as well as advocacy for ... Works in Holmdel, NJ on February 23. The Council's Innovation Forecast event ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... it is so critically important that we all are aware of our options ... Mediaplanet is proud to announce the launch of its newest edition of "Vision ...
(Date:2/24/2017)... Abilene, Texas (PRWEB) , ... February 24, 2017 , ... ... article that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an ... of this current generation. He explains that the Bible details the current times ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over ... on February 12th. Ms. Esparza qualified into this prestigious status after winning ... in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Club in Miami Beach to host its Swirl: Miami Wine Tasting Event on ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... , Feb. 23, 2017  The particle ... million by 2021 from USD 275.9 million in ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... spending on pharmaceutical R&D, and growth in manufacturing ... the market growth for particle counters. On the ...
(Date:2/23/2017)... BOSTON , Feb. 23, 2017 ... devices and services since 1997, is changing the ... modern technology providing patients with pro-active, custom-made solutions. ... desire for instant and affordable healthcare without walls, ... of high-level devices developed with healthcare professionals that ...
Breaking Medicine Technology: